DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics units and Abcam acquisition add upside potential.

The stock's fall snapped a two-day winning streak.

President Donald Trump’s new second term is young, but some of its patterns are already clear. The President has no interest ...

Shares of Waters Corp. slid 3.16% to $287.53 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.01% to 6,296.79 and Dow Jones ...

The VOO ETF stock price continued to soar this week, as the Fear and Greed Index rose. Explore what to expect as key analyst ...

A lot could happen on the trade front in the next few weeks, from pressuring Russia on Ukraine to arguing the legality of the ...

A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...